Screener
CNO Financial Group CNO Medicare supplement — Issuances
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by CNO Financial Group in its filing.
Tagged under the XBRL concept us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance.
The source filing: CNO Financial Group’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001224608-26-000064
| Beginning PVEFPB at original discount rate | 6,343.4 | 3,984.6 | 4,419.7 | 4,877.3 | 271.1 | 19,896.1 | ||||||
| Effect of actual variances from expected experience | 18.1 | 30.9 | (44.5) | (57.3) | (0.5) | (53.3) | ||||||
| Adjusted beginning of period PVEFPB | 6,361.5 | 4,015.5 | 4,375.2 | 4,820.0 | 270.6 | 19,842.8 | ||||||
| Issuances | 132.2 | 419.3 | 89.9 | 184.1 | 3.5 | 829.0 | ||||||
| Interest accrual | 147.2 | 88.7 | 115.5 | 106.9 | 6.3 | 464.6 | ||||||
| Benefit payments | (212.9) | (268.4) | (145.1) | (235.5) | (15.1) | (877.0) | ||||||
| Ending PVEFPB at original discount rate | 6,428.0 | 4,255.1 | 4,435.5 | 4,875.5 | 265.3 | 20,259.4 | ||||||
| Effect of changes in discount rate assumptions, end of period | (426.3) | (160.1) | (65.2) | (249.1) | (13.8) | (914.5) |
ITEM 1. FINANCIAL STATEMENTS.
FAQ
- What is CNO Financial Group's medicare supplement — issuances?
- CNO Financial Group (CNO) reported medicare supplement — issuances of $144.3M in Q2 2026.
- How has CNO Financial Group's medicare supplement — issuances changed year-over-year?
- CNO Financial Group's medicare supplement — issuances increased by 50.0% year-over-year, from $96.2M to $144.3M.
- What is the long-term trend for CNO Financial Group's medicare supplement — issuances?
- Over 3 years (2022 to 2025), CNO Financial Group's medicare supplement — issuances has grown at a 18.1% compound annual growth rate (CAGR), from $286.2M to $471.9M.
- What does medicare supplement — issuances mean?
- Tracks the total value or volume of new Medicare Supplement policies issued during a specific reporting period. This is a primary indicator of sales momentum and market penetration within the target demographic. Growth in issuances reflects the effectiveness of the company's distribution channels and competitive positioning.
Ask your AI about CNO Financial Group's medicare supplement — issuances.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude